Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emma Eriksson

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
The Lancet. Oncology|March 28, 2024
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 studyBenjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, et al.
Journal of Pharmaceutical Sciences|November 13, 2022
The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine DendrimerNadim Akhtar, Marianne B Ashford, Louisa Beer, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
The Lancet. Oncology|March 28, 2024
LOAd703, an oncolytic virus-based immunostimulatory gene therapy, combined with chemotherapy for unresectable or metastatic pancreatic cancer (LOKON001): results from arm 1 of a non-randomised, single-centre, phase 1/2 studyBenjamin L Musher, Eric K Rowinsky, Brandon G Smaglo, et al.
Journal of Pharmaceutical Sciences|November 13, 2022
The Global Characterisation of a Drug-Dendrimer Conjugate - PEGylated poly-lysine DendrimerNadim Akhtar, Marianne B Ashford, Louisa Beer, et al.
Pageof 5